Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-27

Clinical Trial Update: Imaging Modality Effects on the Multi-dimensional InfraRed Analysis (MIRA) Technology

View source ↗

Summary

A clinical trial evaluating the MIRA imaging technology for breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Real Imaging Ltd. | Conditions: Breast Cancer | Status: WITHDRAWN